Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
- 1 December 2006
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 108 (12), 3739-3745
- https://doi.org/10.1182/blood-2006-05-024711
Abstract
The HLA class I/II alleles and the tumor necrosis factor α (TNFA) locus are closely linked in the MHC complex. We have characterized the causative factor VIII mutation, HLA alleles as well as 4 polymorphisms (–827C>T, –308G>A, –238A>G, and 670A>G) in the TNFA gene in 164 patients (124 severe, 26 moderate, and 14 mild) in 78 families with hemophilia A enrolled in the Malmö International Brother Study (MIBS). Inhibitors were identified in 77.8% of patients with a single haplotype (Hap 2) and 72.7% of the patients with the TNFA –308 A/A genotype within this haplotype compared with 39.7% for TNFA –308 G/G patients and 46.9% for TNFA –308 G/A heterozygotes (OR 4.0; 95% CI, 1.4-11.5; P = .008). The association between the –308 A/A genotype and inhibitors was enhanced in subgroups of patients with severe hemophilia (OR 19.2; 95% CI 2.4-156.5; P < .001) and with inversions (n = 75; OR, 11.8; 95% CI, 1.3-105.1; P = .013). Associations were found for the HLA A26 and B44 alleles, but these were not consistent in the subgroup analysis. Our data imply that the TNFA –308G>A polymorphism within Hap 2 is a useful marker and potential modulator of the immune response to replacement therapy in patients with hemophilia.Keywords
This publication has 19 references indexed in Scilit:
- Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia ABlood, 2006
- Inhibitors in congenital coagulation disordersBritish Journal of Haematology, 2004
- The epidemiology of inhibitors in haemophilia A: a systematic reviewHaemophilia, 2003
- The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor developmentHaemophilia, 2001
- Tumour necrosis factor-α polymorphism and secretion in myasthenia gravisJournal of Neuroimmunology, 1999
- The genetic basis of inhibitor development in haemophilia AHaemophilia, 1998
- Secretion of Tumour Necrosis Factor α and Lymphotoxin α in Relation to Polymorphisms in the TNF Genes and HLA‐DR Alleles. Relevance for Inflammatory Bowel DiseaseScandinavian Journal of Immunology, 1996
- Dinucleotide repeat polymorphism at the human gene for the brainderived neurotrophic factor (BDNF)Human Molecular Genetics, 1992
- Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes.Proceedings of the National Academy of Sciences of the United States of America, 1987
- Human Lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localizationNucleic Acids Research, 1985